Global Database of Emerging Companies

A powerful research and due diligence tool for investors, entrepreneurs, and business development executives

The OneMedPlace Global Database is the best first stop to learning about the companies and technologies shaping the future of health and medicine. To gain access to full access to this database register.

Searched: Market-Research-Services             1 - 30 of 59 results       Next >

OneMedRadio: Dr. Daniel Teper, CEO of Immune Pharmaceuticals

OneMedRadio interviews Dr. Daniel Teper, Founder and CEO of Immune Pharmaceuticals, about the development of first-in-class monocolonal antibodies, and the market opportunity in the treatment of inflammatory diseases and cancer.


Prospect Biosystems, Inc.

Prospect Biosystems is an innovative developer and provider of products uniquely serving the Sample Preparation needs of the Proteomics market. Our products provide up-stream sample processing and are complementary to existing analytical instrumentation.


InHealth 2010: Robert Rubin Interview

Robert J. Rubin, MD, clinical professor of medicine at Georgetown University, chair of the InHealth research council, and conference chair, discusses the potential effects of recent healthcare reform legislation at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC.


InHealth 2010 Health Technology Summit: Methods for Medtech: Taming Comparative Effectiveness and Other Challenges (Part 6 of 6)

Peter J. Neumann, ScD, Director of the center for the evaluation of value and risk in health at Tufts University, and Stephen J. Northrup, Principal with the Podesta Group, examine the trends in comparative effectiveness research in a discussion moderated by Robert Rubin at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 6 of 6.


InHealth 2010 Health Technology Summit: Methods for Medtech: Taming Comparative Effectiveness and Other Challenges (Part 5 of 6)

Peter J. Neumann, ScD, Director of the center for the evaluation of value and risk in health at Tufts University, and Stephen J. Northrup, Principal with the Podesta Group, examine the trends in comparative effectiveness research in a discussion moderated by Robert Rubin at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 5 of 6.


InHealth 2010 Health Technology Summit: Methods for Medtech: Taming Comparative Effectiveness and Other Challenges (Part 4 of 6)

Peter J. Neumann, ScD, Director of the center for the evaluation of value and risk in health at Tufts University, and Stephen J. Northrup, Principal with the Podesta Group, examine the trends in comparative effectiveness research in a discussion moderated by Robert Rubin at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 4 of 6.


InHealth 2010 Health Technology Summit: Methods for Medtech: Taming Comparative Effectiveness and Other Challenges (Part 2 of 6)

Peter J. Neumann, ScD, Director of the center for the evaluation of value and risk in health at Tufts University, and Stephen J. Northrup, Principal with the Podesta Group, examine the trends in comparative effectiveness research in a discussion moderated by Robert Rubin at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 2 of 6.


InHealth 2010 Health Technology Summit: Methods for Medtech: Taming Comparative Effectiveness and Other Challenges (Part 3 of 6)

Peter J. Neumann, ScD, Director of the center for the evaluation of value and risk in health at Tufts University, and Stephen J. Northrup, Principal with the Podesta Group, examine the trends in comparative effectiveness research in a discussion moderated by Robert Rubin at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 3 of 6.


InHealth 2010 Health Technology Summit: Methods for Medtech: Taming Comparative Effectiveness and Other Challenges (Part 1 of 6)

Peter J. Neumann, ScD, Director of the center for the evaluation of value and risk in health at Tufts University, and Stephen J. Northrup, Principal with the Podesta Group, examine the trends in comparative effectiveness research in a discussion moderated by Robert Rubin at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 1 of 6.


InHealth 2010: Alan Garber Interview

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, talks about recent healthcare reform legislation, and the possibility that raising the retirement eligibility age could increase the nation’s GDP and help to pay for reformed healthcare, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC.


InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 5 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 5 of 5.


InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 3 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 3 of 5.


InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 4 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 4 of 5.


InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 2 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 2 of 5.


InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 1 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 1 of 5.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 2 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 2 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 8 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 8 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 7 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 7 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 6 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 6 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 3 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 3 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 4 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 4 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 5 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 5 of 8.


InHealth 2010 Health Technology Summit: Medtech Innovation in a Reformed Delivery System (Part 1 of 8)

Alan M. Garber, MD, PhD, professor of medicine and director of the center for health policy and center for primary care and outcomes research at Stanford University, provides a keynote address about the role of medical technologies after the recent enactment of healthcare reform legislation, and answers questions from the audience, at the InHealth 2010 Health Technology Summit, held April 7, in Washington, DC. Part 1 of 8.


Applechem Laboratories

Applechem Laboratories researches, develops, manufactures, and markets specialty intermediates and ingredients to consumer product companies.


OMFNY2011 Presentation: Thermogenesis

ThermoGenesis offers physicians, researchers, hospitals, and blood banks a wide range of cell-based systems, long-term knowledge and experience, and future-oriented research and development. They are dedicated to advancing technologies and improving lives.


Management Interview: MDCI (Medical Device Consultants)

MDCI is a contract research organization and consulting firm that works with emerging and established firms to commercialize medical devices, in vitro diagnostics and combination products.


OMFNY2011 Presentation: NeoStem

NeoStem, Inc. is an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units: (i) U.S. adult stem cells, (ii) China adult stem cells, (iii) China pharmaceuticals. These business units are expected to provide platforms for the accelerated development and commercialization of innovative technologies and products in both the U.S. and China.


Video News Release: Aureon in the Journal of Urology

Aureon specializes in predictive clinical tests for cancer care and bio-pharmaceutical research and development. They were given a stellar review in the Journal of Urology for their technology. Vijay Aggarwal of Aureon talks about the review.


Genomic Expression at OneMedForum New York 2010

Gitte L. Pedersen, President and CEO of Genomic Expression, presents at OneMedForum New York 2010.


Searched: Market-Research-Services             1 - 30 of 59 results       Next >